Alurar rigakafin typhoid
Alurar rigakafin typhoid alluran rigakafi ne da ke hana zazzabin typhoid. Akwai nau'o'i da yawa: maganin typhoid conjugate (TCV), Ty21a (alurar rigakafi mai rai ) da Vi capsular polysaccharide (ViPS) ( alurar riga- kafi).[1] Suna da kusan kashi 30 zuwa 70% masu tasiri a cikin shekaru biyu na farko, ya danganta da takamaiman maganin da ake tambaya. An nuna maganin rigakafin Vi-rEPA yana da amfani ga yara. maganan gaskin gyaran ne ake tayi dimin samun damar.
 Alurar rigakafin typhoid | |
|---|---|
essential medicine (en)  da vaccine type (en) | |
 | |
| Bayanai | |
| Ƙaramin ɓangare na | typhoid-paratyphoid vaccines (en) |
| Vaccine for (en) | Zazzabin Rawaya |
| WordLift URL (en) | http://data.medicalrecords.com/medicalrecords/healthwise/typhoid_vaccines__what_you_need_to_know |
Amfanin likitanci
Ty21a, maganin Vi capsular polysaccharide, da Vi-rEPA suna da tasiri wajen rage zazzaɓin typhoid tare da ƙananan sakamako masu illa. Sabbin alluran rigakafi irin su Vi-TT (PedaTyph) suna jiran [yaushe?] gwaje-gwajen filin don nuna inganci a kan fallasa na halitta. Alurar rigakafi ta baka ta Ty21a tana hana kusan rabin cututtukan taifot a cikin shekaru uku na farko bayan alurar riga kafi.[2] Alurar rigakafin Vi polysaccharide mai allura ya hana kusan kashi biyu bisa uku na cututtukan typhoid a cikin shekara ta farko kuma yana da ingantaccen tasiri na 55% a shekara ta uku. An nuna ingancin waɗannan alluran rigakafin a cikin yara waɗanda suka wuce shekaru biyu kawai. Alurar rigakafin Vi-rEPA, sabon nau'i na haɗin gwiwa na allurar Vi, na iya zama mafi inganci kuma yana hana cutar a yawancin yara 'yan ƙasa da shekaru biyar. A cikin gwaji a cikin yara masu shekaru 2 zuwa 5 a Vietnam, maganin yana da inganci fiye da kashi 90 cikin ɗari a cikin shekara ta farko kuma kariya ta ɗauki akalla shekaru huɗu.[3]
Jadawalin
Dangane da tsarin za a iya ba da shi tun yana ɗan shekara biyu (ViPS), shida (Ty21a), ko wata shida (TCV)[3][4]
